IL6, IL8, and IL10 in the distinction of malignant ovarian neoplasms and endometriomas
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This study found that elevated serum concentrations of IL-6, IL-8, and IL-10 can differentiate ovarian malignancies from endometriomas.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PROBLEM: Studies have shown a relationship between endometriosis and ovarian cancer. Our aims were to evaluate and compare the dosages of cytokines IL-2, IL-5, IL-6, IL-8, IL-10, and TNF-α in serum, intracystic fluid, and peritoneal fluid of patients with ovarian endometrioma, malignant and benign ovarian neoplasms, and non-neoplastic ovarian tumors; to verify if there is a correlation between the values of these cytokines between ovarian endometrioma and ovarian malignancy; and to determine the best cut-off point for serum cytokines that can be used to differentiate patients with ovarian malignancy and endometrioma. METHOD OF STUDY: The concentrations of cytokines were quantified by enzyme-linked immunosorbent assay (ELISA), analyzed by Kruskal-Wallis test with the Dunn post-test. Receiver operating feature (ROC) curve was used to obtain the area under the curve (AUC) and to determine the best cut-off values that could be used in the diagnosis of ovarian malignancy. Correlations of cytokine concentrations were performed by the Spearman test. RESULTS: IL-6, IL-8, and IL-10 concentrations were higher in patients with malignant neoplasia. When evaluating the area under the curve (AUC) of serum cytokine levels comparing patients with malignant neoplasia and endometriomas, there was statistical significance for IL-6, IL-8, and IL-10. CONCLUSION: Our results showed utility in serum concentrations of IL-6, IL-10, and IL-8 as parameters that differentiate endometriomas from ovarian malignancies.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (39)
- <b>Ovarian atypical endometriosis: its close association with malignant epithelial tumours</b> via openalex
- Cellular, Histologic, and Molecular Changes Associated With Endometriosis and Ovarian Cancer via openalex
- Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis via openalex
- Cyst fluid hemoglobin species in endometriosis and its malignant transformation: The role of metallobiology via openalex
- Degranulating Eosinophils in Human Endometriosis via openalex
- Diagnosis and management of endometriosis: The role of the advanced practice nurse in primary care via openalex
- ENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN THAT ORGAN via openalex
- Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development via openalex
- Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis via openalex
- Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas via openalex
- Inflammatory cytokine profile of co‑cultivated primary cells from the endometrium of women with and without endometriosis via openalex
- New insights in the pathophysiology of ovarian cancer and implications for screening and prevention via openalex
- Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers via openalex
- Ovarian cancer in endometriosis: an update on the clinical and molecular aspects via openalex
- Ovarian endometriosis via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery via openalex
- Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies via openalex
- Serum anti-inflammatory cytokines for the evaluation of inflammatory status in endometriosis via openalex
- The peritoneal environment in endometriosis via openalex
- W2127387778 via openalex
- W2135866806 via openalex
- W2042633087 via openalex
- W2032458681 via openalex
- W2159228424 via openalex
- W2020209998 via openalex
- W2011027131 via openalex
- W2397044959 via openalex
- W2005817166 via openalex
- W2752182706 via openalex
- W1999794291 via openalex
- W1988742135 via openalex
- W2902023274 via openalex
- W2903735728 via openalex
- W2064931633 via openalex
- W2991448883 via openalex
- W2095818256 via openalex
- W2063553068 via openalex
- W2125681453 via openalex
Cited by (5)
- Serum Interleukin-6 Levels in Endometriosis and Endometriosis-Associated Ovarian Cancer: A Systematic Review and Meta-Analysis Demonstrating a Biological Gradient 2026
- Insights into inflammatory gene expression in endometriosis: a comparative evaluation of tissue biopsy samples 2025
- Therapeutic targeting of interleukin-17C signaling in carcinogenesis of endometriosis 2025
- Endometriosis and the Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Pathophysiology: A Narrative Review of the Literature 2024
- Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis. 2021
Source provenance
- europepmc
- last seen: 2026-09-27T09:11:36.575535+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:21:53.586419+00:00
License: CC0
· commercial use OK